Income Statement
ORCHESTRA BIOMED HOLDINGS, INC.
OBIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
33.48 | 2.64 | 2.76 | - | - | - |
|
Cost of Revenue
|
0.19 | 0.20 | 0.19 | - | - | - |
|
Gross Profit
|
33.29 | 2.43 | 2.57 | - | - | - |
|
Operating Expenses
|
85.10 | 66.74 | 54.08 | 2.96 | 0.27 | 0.00 |
|
Research & Development
|
58.19 | 42.80 | 33.82 | - | - | - |
|
Selling, General & Administrative
|
26.91 | 23.93 | 20.26 | 2.96 | 0.27 | - |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-51.81 | -64.30 | -51.51 | -2.96 | -0.27 | - |
|
Non-Operating Income
|
- | - | - | - | - | - |
|
Interest Income
|
- | - | - | 0.35 | - | - |
|
Interest Expense
|
1.90 | 0.30 | 1.40 | - | - | - |
|
Other Non-Op Income / Expense
|
- | -0.01 | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-52.70 | -61.02 | -49.12 | -2.74 | -0.38 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-51.48 | -63.99 | -51.22 | -2.96 | -0.27 | 0.00 |
|
Earnings Per Share (Basic)
|
-1.11 | -1.66 | -1.48 | -0.17 | - | - |
|
Diluted EPS
|
-1.11 | -1.66 | -1.48 | - | - | - |
|
Weighted Average Shares
|
47.75 | 36.82 | 33.23 | 16.43 | - | - |
|
Diluted Weighted Avg Shares
|
47.75 | 36.82 | 33.23 | - | - | - |
|
Comprehensive Income
|
-52.69 | -60.96 | -49.12 | - | - | - |